VOLITIONRX LTD Contracts & Agreements
105 Contracts & Agreements
- Business Finance (22 contracts)
- Business Formation (1)
- Business Operations (3)
- Human Resources (25)
- Intellectual Property (4)
- Real Estate (1)
- Uncategorized (49)
- Contract of Employment, by and between Volition Diagnostics UK Ltd. And Dr. Andrew Retter, dated March 19, 2024 (Filed With SEC on March 25, 2024)
- 2015 Stock Incentive Plan, as amended (Filed With SEC on June 30, 2023)
- Underwriting Agreement, dated June 1, 2023, by and between VolitionRx Limited and Prime Executions, Inc. dba Freedom Capital Markets (Filed With SEC on June 5, 2023)
- Form of Underwriter Warrant (Filed With SEC on June 5, 2023)
- Singapore Volition Pte. Limited Employment Agreement Group Chief Executive Officer, dated March 13, 2023, by and between Singapore Volition and Cameron Reynolds (Filed With SEC on March 15, 2023)
- Underwriting Agreement, dated February 17, 2023, by and between VolitionRx Limited and Newbridge Securities Corporation (Filed With SEC on February 21, 2023)
- Underwriting Agreement, dated July 29, 2022, by and between VolitionRx Limited and Newbridge Securities Corporation (Filed With SEC on August 2, 2022)
- 2015 Stock Incentive Plan, as amended (Filed With SEC on June 14, 2022)
- Equity Distribution Agreement, dated May 20, 2022, by and between VolitionRx Limited and Jefferies LLC (Filed With SEC on May 20, 2022)
- License and Supply Agreement between Belgian Volition and Heska Corporation, dated March 28, 2022 (Filed With SEC on May 11, 2022)
- Employment Agreement by and between Volition America, Inc. and Gaetan Michel, dated effective September 15, 2021 (Filed With SEC on November 10, 2021)
- Consulting Services Agreement by and between Volition Global Services SRL and 3F Management SPRL (Gaetan Michel), dated effective September 15, 2021 (Filed With SEC on November 10, 2021)
- Employment Agreement by and between Volition Diagnostics UK Limited and Nick Plummer, dated August 23, 2021 (Filed With SEC on November 10, 2021)
- VOLITIONRX LIMITED 2015 STOCK INCENTIVE PLAN As amended March 31, 2021 ARTICLE 1 PURPOSES OF THE PLAN (Filed With SEC on June 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on May 11, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on May 11, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- VOLITION AMERICA, INC. EMPLOYMENT AGREEMENT GROUP CHIEF COMMERCIAL OFFICER (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- VOLITIONRX LIMITED 3,809,524 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement (Filed With SEC on February 12, 2021)
- VOLITIONRX LIMITED $25,000,000 COMMON STOCK EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on November 12, 2020)
- CONSULTING SERVICES AGREEMENT (Filed With SEC on November 12, 2020)
- 4,365,000 Shares* VOLITIONRX LIMITED Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 22, 2020)
- DESCRIPTION OF CAPITAL STOCK (Filed With SEC on February 20, 2020)
- AMENDMENT #1 TO CLINICAL STUDY AGREEMENT (Filed With SEC on February 20, 2020)
- VOLITIONRX LIMITED 2015 STOCK INCENTIVE PLAN As amended March 27, 2019 ARTICLE 1 PURPOSES OF THE PLAN (Filed With SEC on June 18, 2019)
- VOLITIONRX LIMITED 2015 STOCK INCENTIVE PLAN As amended June 15, 2018 ARTICLE 1 PURPOSES OF THE PLAN (Filed With SEC on September 11, 2018)
- COMMON STOCK PURCHASE AGREEMENT by and between VolitionRx Limited and Cotterford Company Limited August 8, 2018 TABLE OF CONTENTS (Filed With SEC on August 9, 2018)
- 3,500,000 Shares* VOLITIONRX LIMITED Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 12, 2018)
- CLINICAL STUDY AGREEMENT (Filed With SEC on November 9, 2017)
- Unofficial English Translation of a French Document UNSECURED CREDIT AGREEMENT (Filed With SEC on September 21, 2017)
- VOLITIONRX LIMITED 2015 STOCK INCENTIVE PLAN As adopted by the Board of Directors on August 18, 2015 and amended on August5, 2016 and June 13, 2017 ARTICLE 1 PURPOSES OF THE PLAN (Filed With SEC on September 12, 2017)
- REAL ESTATE CAPITAL LEASE AGREEMENT (Filed With SEC on October 31, 2016)
- Stphane Watillon & Pierre Hams, Associated civil-law notaries Civil-law partnership under the form of a private limited company, rue J. Saintraint, 8 NAMUR RLP 862.279.421. (Filed With SEC on October 31, 2016)
- VOLITIONRX LIMITED 2,250,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on September 30, 2016)
- FIRST AMENDMENT TO EXECUTIVE CHAIRMANS AGREEMENT (Filed With SEC on May 13, 2016)
- CONSULTANCY AGREEMENT (Filed With SEC on May 13, 2016)
- FIRST AMENDMENT TO CONSULTANCY AGREEMENT (Filed With SEC on May 13, 2016)
- Offices of Matres Stphane Watillon & Pierre Hams, a partnership of notaries, in Namur Tel. 081/22.91.23 (Filed With SEC on May 13, 2016)
- 3,769,231 Shares* VOLITIONRX LIMITED Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 18, 2016)
- VOLITIONRX LIMITED EMPLOYMENT AGREEMENT CHIEF MEDICAL OFFICER & HEAD OF U.S. OPERATIONS (Filed With SEC on March 11, 2016)
- VOLITIONRX LIMITED EMPLOYMENT AGREEMENT CHIEF FINANCIAL OFFICER (Filed With SEC on March 11, 2016)
- EXECUTIVE CHAIRMANS AGREEMENT (Filed With SEC on May 12, 2015)
- INDEPENDENT DIRECTOR AGREEMENT (Filed With SEC on May 12, 2015)
- Schedule no 1 to Master Consultancy Agreement between OncoLytika (the Consultancy) and Volition (the Client) dated 01 October 2010 (the Master Agreement) (Filed With SEC on May 12, 2015)
- Schedule no 1 to Master Consultancy Agreement between OncoLytika (the Consultancy) and Belgian Volition SA. (the Client) dated 01 January 2014 (the Master Agreement) (Filed With SEC on May 12, 2015)
- VOLITIONRX LIMITED [] SHARES OF COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on February 4, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT CAMERON REYNOLDS (Filed With SEC on January 23, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 23, 2015)
- VOLITIONRX LIMITED EMPLOYMENT AGREEMENT CORPORATE SECRETARY (Filed With SEC on January 23, 2015)
- Master Consultancy Services Agreement (October 2010 revision) (Filed With SEC on January 23, 2015)
- Agreement (Filed With SEC on January 23, 2015)
- VOLITIONRX LIMITED (Filed With SEC on January 23, 2015)
- (1) PB COMMODITIES PTE LTD - and - (2) CAMERON REYNOLDS ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ (Filed With SEC on January 8, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT CAMERON REYNOLDS (Filed With SEC on January 8, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 8, 2015)
- VOLITIONRX LIMITED EMPLOYMENT AGREEMENT CORPORATE SECRETARY (Filed With SEC on January 8, 2015)
- (1) PB COMMODITIES PTE LTD - and - (2) CAMERON REYNOLDS ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ (Filed With SEC on January 8, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT CAMERON REYNOLDS (Filed With SEC on January 8, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 8, 2015)
- VOLITIONRX LIMITED EMPLOYMENT AGREEMENT CORPORATE SECRETARY (Filed With SEC on January 8, 2015)
- COMMON STOCK PURCHASE AGREEMENT by and between VolitionRX Limited and The Purchasers Identified on Schedule I Hereto February 26, 2014 TABLE OF CONTENTS (Filed With SEC on February 28, 2014)
- Master Consultancy Services Agreement (November 2010 revision) (Filed With SEC on April 1, 2013)
- (1) BELGIAN VOLITION S.A. - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on April 1, 2013)
- Development of diagnostic blood tests, cancer prognosis Study with preservation of blood samples (Filed With SEC on October 4, 2012)
- Exhibit 2.1 DATED 22 September 2010 SINGAPORE VOLITION Pte LIMITED and VALIRX PLC AGREEMENT for the sale and purchase of securities in ValiBIO SA... (Filed With SEC on May 8, 2012)
- AGREEMENT, CONSENT AND WAIVER (Filed With SEC on April 5, 2012)
- Exhibit 10.9 DATED 2010 (1) CHROMA THERAPEUTICS LIMITED - and - (2) VALIRX PLC - and - (3) VALIBIO SA - and - (4) SINGAPORE VOLITION PTE. LIMITED... (Filed With SEC on February 24, 2012)
- Exhibit 10.23 Terms & Conditions of Employment for Executive Officer (Filed With SEC on February 24, 2012)
- Exhibit 10.24 (Filed With SEC on February 24, 2012)
- Exhibit 10.25 (Filed With SEC on February 24, 2012)
- Exhibit 10.26 DATED: October 04, 2010 (1) PB COMMODITIES PTE LTD - and - (2) KENDALL LIFE SCIENCES CONSULTANTS LTD ___________________________________________ CONSULTANCY... (Filed With SEC on February 24, 2012)
- Exhibit 10.27 (Filed With SEC on February 24, 2012)
- Exhibit 10.1 Patent License Agreement (Filed With SEC on February 24, 2012)
- Exhibit 10.5 (Filed With SEC on February 24, 2012)
- Exhibit 10.6 (Filed With SEC on February 24, 2012)
- Exhibit 10.8 DATED 22 September 2010 SINGAPORE VOLITION Pte LIMITED and VALIRX PLC _______________________________________________________ AGREEMENT for the sale and purchase of... (Filed With SEC on February 24, 2012)
- Exhibit 10.1 Patent License Agreement (Filed With SEC on January 11, 2012)
- Exhibit 10.2 (Filed With SEC on January 11, 2012)
- Exhibit 10.3 (Filed With SEC on January 11, 2012)
- Exhibit 10.4 (Filed With SEC on January 11, 2012)
- Exhibit 10.5 (Filed With SEC on January 11, 2012)
- Exhibit 10.6 (Filed With SEC on January 11, 2012)
- Exhibit 10.7 (Filed With SEC on January 11, 2012)
- Exhibit 10.8 DATED 22 September 2010 SINGAPORE VOLITION Pte LIMITED and VALIRX PLC _______________________________________________________ AGREEMENT for the sale and purchase of... (Filed With SEC on January 11, 2012)
- Exhibit 10.9 DATED ______________________________________________________________2010 (1) CHROMA THERAPEUTICS LIMITED - and - (2) VALIRX PLC - and - (3) VALIBIO SA - and - (4)... (Filed With SEC on January 11, 2012)
- Exhibit 10.10 SINGAPORE VOLITION PTE. LIMITED (Filed With SEC on January 11, 2012)
- Exhibit 10.11 SINGAPORE VOLITION PTE. LIMITED (Filed With SEC on January 11, 2012)
- Exhibit 10.12 (Filed With SEC on January 11, 2012)
- Exhibit 10.13 (Filed With SEC on January 11, 2012)
- Exhibit 10.14 LICENSE AGREEMENT (Filed With SEC on January 11, 2012)
- Exhibit 10.15 SUPPLEMENTARY AGREEMENT TO THE SHARE PURCHASE AGREEMENT (Filed With SEC on January 11, 2012)
- Exhibit 10.16 DATED______________________________________________________________________2012 (1) IMPERIAL INNOVATIONS LIMITED - and - (2) VALIPHARMA LIMITED - and - (3)... (Filed With SEC on January 11, 2012)
- Exhibit 10.17 (Filed With SEC on January 11, 2012)
- Exhibit 10.18 (Filed With SEC on January 11, 2012)
- Exhibit 10.19 (Filed With SEC on January 11, 2012)
- Exhibit 10.20 (Filed With SEC on January 11, 2012)
- Exhibit 10.21 (Filed With SEC on January 11, 2012)
- VOLITIONRX LIMITED 2011 EQUITY INCENTIVE PLAN (Filed With SEC on November 18, 2011)
- VOLITIONRX LIMITED 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 18, 2011)
- VOLITIONRX LIMITED 2011 EQUITY INCENTIVE PLAN STOCK AWARD AGREEMENT FOR RESTRICTED STOCK (Filed With SEC on November 18, 2011)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on September 29, 2011)
- LETTER OF INTENT (Filed With SEC on March 21, 2011)
